Sponsored research and public-sector collaborations often come with hidden constraints on intellectual property, data use, and exclusivity. AN Law Firm advises companies on navigating these issues so research partnerships support, rather than limit, long-term commercialization goals.
Technology transfer plays a crucial role in turning research discoveries into innovations that reach the public. Universities and government agencies are major sources of breakthrough technologies, from biomedical advances to cutting-edge software. But moving these ideas from the lab or agency into the private sector is rarely simple. This process requires careful legal structuring, negotiation, and the protection of intellectual property rights to be successful. At AN Law Firm, P.C., we use our experience working in university and government technology transfer to help clients navigate the unique legal frameworks of university and government technology transfer.
University and Government Research Collaborations and Technology Transfer
Universities and federal labs are major sources of IP, know-how, data, and talent. The legal framework for sponsored research, licensing, and public funding is rife with issues that can materially affect IP positions and commercialization planning. Those issues can include data use restrictions and government and sponsor rights that may attach through funding or contracting.
AN Law Firm advises companies on structuring, negotiating, and documenting research collaborations and technology transfer arrangements with universities and government entities, with careful attention to intellectual property and data rights.
Company and University Collaborations
University templates typically center the institution’s academic mission, including publication, student participation, and institutional IP policies. For companies, that can create friction with product development, financing, confidentiality, and exclusivity needs.
We counsel companies in connection with:
- Sponsored Research Agreements (SRAs) and related research funding arrangements
- Option and license structures tied to research programs
- IP allocation and definitions (background IP, project IP, improvements, derivative works)
- Data rights (use, sharing, retention, de-identification, ML training permissions, deliverables)
- Publication review and confidentiality provisions
- Sublicensing and field of use terms
- Common operational issues involving students, visiting researchers, and materials
Federal R&D Collaborations and Federal Lab Tech Transfer
Working with federal agencies and laboratories can introduce statutory and contractual requirements that impact licensing structure, exclusivity, reporting, and government use rights.
We advise companies pursuing or operating under:
- Federal lab licenses and collaborations, including CRADAs and related agreements
- Government-funded development where Bayh Dole obligations or government license rights may apply
- Negotiations involving exclusivity constraints, government retained rights, and related compliance issues
- IP and data rights positioning in government facing agreements and flow down contexts
Licensing University Originated or Government Funded Technology
When licensing technology that originated in a university setting, the license terms are only part of the analysis. Funding history, chain of title, institutional policies, and third party rights can affect what is being licensed and what rights may already exist.
We assist companies with:
- Diligence on funding sources, ownership, and encumbrances that can affect scope of rights
- Negotiation of license economics and diligence milestones
- Prosecution control, enforcement rights, improvements, and grant back provisions
- Sublicensing flexibility and field of use definitions
How We Support Clients
We provide legal support across the lifecycle of research collaborations and technology transfer matters, including early term sheet stages through negotiation, execution, and post signature questions:
Deal structuring, drafting, and negotiation (sponsored research agreements, clinical trial agreements, CRADAs, options, licenses, amendments)
- IP ownership and control (foreground and background, improvements, “related” IP, prosecution, enforcement)
- Data rights and restrictions (use rights, sharing, publications, deliverables, ML training permissions)
- Compliance and risk management tied to public funding and government collaboration frameworks
- Commercial contracting support for downstream licensing and collaboration arrangements
Reach Out to AN Law Firm
Our goal is to bridge the gap between research and commercialization. If you are ready to learn how we support clients in turning innovation into marketable solutions, reach out for a private consultation today.